Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the clinical performance of DAILIES TOTAL1 ( DT1) contact lenses with Infuse contact lenses.
Subjects will wear two products and be expected to attend 3 office visits. The individual duration of participation will be approximately 3 weeks, which includes 16 to 22 days of lens wear.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Alcon Investigator 6355
Orlando, Florida, United States
Alcon Investigator 6418
Tallahassee, Florida, United States
Alcon Investigator 3950
Bloomington, Illinois, United States
Alcon Investigator 6614
Franklin Park, Illinois, United States
Alcon Investigator 6583
Eden Prairie, Minnesota, United States
Alcon Investigator 3382
Wyomissing, Pennsylvania, United States
Alcon Investigator 6353
Memphis, Tennessee, United States
Alcon Investigator 2786
Memphis, Tennessee, United States
Start Date
August 31, 2021
Primary Completion Date
October 12, 2021
Completion Date
October 12, 2021
Last Updated
November 8, 2022
112
ACTUAL participants
Delefilcon A contact lenses
DEVICE
Kalifilcon A contact lenses
DEVICE
Lead Sponsor
Alcon Research
NCT05458323
NCT07322211
NCT07078799
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions